Manuel Mohr

Company: D2B3

Job title: Co-Founder & Chief Executive Officer

Seminars:

Workshop B: Advancing Gene Therapy to Treat Alzheimer’s & Parkinson’s Disorders 10:30 am

As the last couple of years have welcomed approved neurological gene therapies from Bluebird Bio, PTC Therapeutics, Novartis, Sarepta Therapeutics, what is the route forward for gene therapy development for Alzheimer’s & Parkinson’s disease? This workshop explores the most recent developments in gene therapy, including brain delivery, preclinical models, translation of gene therapy research into…Read more

day: Pre-Conference Workshop Day